Hormonal Manipulation in Breast Cancer: Understanding Treatment Options

Hormones play a crucial role in many breast cancers. If your cancer is estrogen receptor-positive (ER+) or progesterone receptor-positive (PR+), it means the cancer cells use these hormones to grow. By blocking or lowering these hormones, doctors can effectively slow or stop cancer growth. This type of treatment is known as hormonal (or endocrine) therapy, and it’s a vital part of breast cancer care.

In this guide, we’ll explore the main prescription options, natural supportive therapies, and what to watch out for in terms of side effects.

Prescription Hormonal Therapies

1. Tamoxifen (Selective Estrogen Receptor Modulators - SERMs)

• How it works: Tamoxifen blocks estrogen receptors in breast tissue but acts like estrogen in other parts of the body, such as bones and cholesterol levels. This is why it is called a "Selective" Estrogen Receptor Modulator.

• Who gets it: Both premenopausal and postmenopausal women.

• Pros: It is effective at reducing recurrence, protects bone health, and improves cholesterol levels.

• Cons: It increases the risk of blood clots and endometrial (womb) cancer. Other side effects include hot flashes and vaginal dryness.

  
  

2. Raloxifene (SERM)

• How it works: Raloxifene is similar to tamoxifen but has different effects in the womb.

• Who gets it: Mainly postmenopausal women at high risk of breast cancer, used as prevention. It is not typically used for women who already have breast cancer.

• Pros: It is safer for the womb since it doesn’t raise endometrial cancer risk. It also has a lower clotting risk than tamoxifen and protects bone health.

• Cons: Raloxifene is less effective than tamoxifen for treating established breast cancer.

  
  

3. Aromatase Inhibitors (AIs) – Anastrozole, Letrozole, Exemestane

• How they work: Aromatase inhibitors block the enzyme aromatase, which produces estrogen in postmenopausal women. This drastically lowers estrogen levels.

• Who gets it: Mostly postmenopausal women or premenopausal women whose ovaries have been suppressed, making aromatase the only source of estrogen. Sometimes, it is used after tamoxifen in sequential therapy.

• Pros: AIs are more effective than tamoxifen at preventing cancer recurrence.

• Cons: They can cause bone thinning (osteoporosis), joint and muscle pain, hot flashes, and increased cholesterol risk.

  
  

4. Ovarian Suppression

This involves the surgical removal of ovaries, radiation, or GnRH analogues therapy (Goserelin, Leuprolide) to reduce estrogen production from ovaries in premenopausal women.

Natural & Supportive Therapies

While natural therapies cannot replace hormonal treatments, they can support your health and help manage side effects.

Cruciferous Vegetables (DIM & I3C)

1. Indole-3-Carbinol (I3C)

• Source: Cruciferous vegetables like broccoli, kale, Brussels sprouts, and cabbage.

• Mechanism: Promotes metabolism of estrogen down the “2-hydroxyestrone” pathway, which is considered less carcinogenic than “16α-hydroxyestrone.” It may reduce estrogen-driven proliferation in ER+ breast cancer.

• Evidence: Preclinical studies show anti-tumor activity. Some early human studies suggest benefits in hormone metabolism, but it is not yet standard clinical therapy.

  
  

2. Diindolylmethane (DIM)

• Source: Formed naturally from I3C during digestion.

• Mechanism: Similar to I3C, DIM favors “good estrogen” metabolism. It has weak selective estrogen receptor modulation activity and shows anti-inflammatory and anti-proliferative effects in lab studies.

• Evidence: Small clinical trials in breast cancer survivors show that DIM supplementation can alter estrogen metabolism in a potentially protective direction. While it is not a substitute for tamoxifen or AIs, it may be supportive.

  
  

Other Helpful Natural / Repurposed Drugs Approaches

• Bone Health: Vitamin D and resistance exercise.

• Joint Pain (from AIs): Omega-3 fatty acids and turmeric (curcumin).

• Memory & Brain Health: Staying mentally and physically active, omega-3s, and B vitamins.

• EGCG: May protect bone and metabolic health.

• Curcumin and resveratrol: Anti-inflammatory, possible synergy with hormonal therapy.

• Soy isoflavones: Mild phytoestrogens that help bone health but should be used cautiously in ER+ breast cancer (dietary intake is usually safe; avoid high-dose supplements).

• Black cohosh: Used for menopausal symptoms, but evidence in breast cancer is mixed, and caution is needed.

• Resveratrol (found in red grapes and berries): May protect cardiovascular health and work synergistically with estrogen-blocking effects.

• COX-2 inhibitors (e.g., celecoxib) or non-selective COX-1 and 2 inhibitors such as Aspirin have been studied as adjuvants in estrogen-dependent cancers — they can reduce prostaglanidine-2 (PGE2) which stimulates the produciton of aromatase enzymes. Aspirin and Celecoxib therefore indirectly lower aromatase activity. This COX2-PGE2-aromatase axis is a crucial mechanism linking chronic inflammation to elevated local estrogen levels, playing a significant role in the development and progression of estrogen-dependent diseases like breast cancer and endometriosis.

  
  

Bioidentical HRT and Breast Cancer: Important Precaution

Some women wonder about “bio-identical hormone replacement therapy (BHRT)” for managing menopause symptoms.

• Systemic bioidentical HRT (patches, creams, pellets, tablets) is not safe for women with breast cancer, especially ER+ cancer. Even though it is “natural,” estrogen is estrogen and can fuel cancer growth.

• Local vaginal estrogen may sometimes be considered for severe dryness, but only after non-hormonal options have failed, and always under oncology supervision (case-by-case).

• Safer alternatives: Vaginal moisturizers, lubricants, and non-hormonal medications (like clonidine) for hot flashes.

There is a suggestion that progesterone may be safe and even beneficial as a maintenance therapy after breast cancer treatment. However, this has not been confirmed. In fact, a recent study from the University of Manchester, led by researchers at The Christie Hospital and published in Nature, indicates that blocking progesterone may actually be more advantageous. This is the link to the study.

.

In summary, even though bioidentical hormones are structurally “natural,” they still carry the same risks in breast cancer as conventional HRT. Major cancer societies and NICE guidance treat them equally.

Also, check our Integrative Supportive Therapies by clicking the button below 

Integrative Oncology Therapies